HIV/AIDS Clinical Trials in New York

Showing 141-160 of 674 trials

An Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials

NCT03337906

An observational study of long-term outcomes of HIV-1 infection in persons who become infected after enrollment in HIV-1 vaccine trials

HIV Infections

HIV Vaccine Trials Network209 participantsStarted Jul 2008

Birmingham, Alabama, United States • San Francisco, California, United States • Decatur, Georgia, United States +18 more locations

COMPLETEDPhase 3< 1 mile

A Study of GSK1349572 Versus Raltegravir (RAL) With Investigator Selected Background Regimen in Antiretroviral-Experienced, Integrase Inhibitor-Naive Adults

NCT01231516

ING111762 is a 48 week, randomized, double-blind, active-controlled, multicenter, parallel group, non-inferiority study. The study will be conducted in at least 688 HIV-1 infected antiretroviral experienced, integrase-naïve subjects. Subjects will be randomized 1:1 to receive GSK1349572 50 mg once daily or raltegravir (RAL) 400 mg twice daily, each added to an investigator selected background regimen consisting of at least one fully active agent plus no more than one second single agent which may or may not be active. Antiviral activity, safety, pharmacokinetics (PK), and development of viral resistance will be evaluated.

Infection, Human Immunodeficiency VirusHIV Infections

ViiV Healthcare724 participantsStarted Oct 2010

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Little Rock, Arkansas, United States +177 more locations

An Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials

A Study of GSK1349572 Versus Raltegravir (RAL) With Investigator Selected Background Regimen in Antiretroviral-Experienced, Integrase Inhibitor-Naive Adults

HIV/AIDS Trials in Other Cities

Gender-Specific Combination HIV Prevention for Youth in High Burden Settings (MP3-Youth)

Lenalidomide in Treating Patients With AIDS-Associated Kaposi's Sarcoma

Pharmacokinetic Study to Evaluate Double-Dose Levonorgestrel Emergency Contraception in Combination With Efavirenz-Based Antiretroviral Therapy or Rifampicin-Containing Anti-Tuberculosis Therapy

Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women

Atazanavir Used in Combination With Other Anti-HIV Drugs in HIV-Infected Infants, Children, and Adolescents

Safety of and Immune Response to a Novel Human Papillomavirus Vaccine in HIV Infected Children

Safety and Immune Response to Vicriviroc in Combination Regimens in HIV-Infected ART Experienced Children and Adolescents

Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy

Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women

A Study of Three Anti-HIV Drug Combinations in Patients Who Have Taken Amprenavir

The Safety and Effectiveness of Zidovudine in the Treatment of Patients With Early AIDS Related Complex

The Safety and Effectiveness of Ganciclovir Used Alone or in Combination With Granulocyte-Macrophage Colony Stimulating Factor in the Treatment of Cytomegalovirus (CMV) of the Eye in Patients With AIDS

A Comparison of Three Treatments for Advanced HIV Disease in Patients Who Have Received Nucleoside Therapy in the Past

A Phase II, Double-Blind Trial of Recombinant Human Nerve Growth Factor for Treatment of HIV-Associated Sensory Neuropathy

Evaluating the Safety and Pharmacokinetics of Raltegravir in Infants

Evaluating the Safety, Tolerability, and Effect of a Human Monoclonal Antibody (VRC01) on Markers of HIV Persistence in HIV-Infected Adults Receiving Antiretroviral Therapy (ART)

A Study of Three Drugs Plus Zidovudine in the Prevention of Infections in HIV-Infected Patients

Evaluating the Safety and Pharmacokinetics of Maraviroc in HIV-1-Exposed Infants at Risk of Acquiring HIV-1 Infection

Other Conditions in New York